P4HB and neoplasm: To implement two-step sequential treatment (Dsi-24h-Dox-24h) in vivo, Dsi RNPs and doxorubicin need to be separately injected into body while maintaining the intervals of time (e.g. one day), and consequently the drug resistance phenotypes should be silenced before doxorubicin is unloaded at tumor sites.